Australia, Oct. 21 -- Revvity Health Sciences Inc., owns the trademark (2574493) for 'MIMIX' till May 22, 2035.
Status: protected:
Registered/protected
Classes: 1 [Biological preparations for laboratory, biopharmaceutical processing, and research purposes, namely, reference standards; biological preparations for cancer research; biological preparations for quality control; cell line-derived reference standards for research purpose; samples for use in biochemical or biological laboratory analysis for research purposes; cell line-derived products for scientific and research purposes, including for clinical investigations and for use in product testing; reference standards used for research purposes, namely, next generation sequencing, droplet-digital, real-time pcr or sanger sequencing.], 5 [Cell line-derived reference standards used in clinical samples; reference standard substances used for clinical tests for medical purposes; reference standards used for next generation sequencing, droplet-digital, real-time pcr or sanger sequencing; reference standards used for detecting chromosomal abnormalities; reference standards used for analysing biological samples.] and 40 [Custom manufacture of cell line-delivered products for medical and commercial applications; custom manufacture of reference standards.]
Type of Mark: Word
Date of Acceptance: Aug. 13
Registration Advertised: Oct. 20
For further details contact Kevin Oliver Revvity Inc. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2574493.
Disclaimer: Curated by HT Syndication.
